YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates

Abstract We recently characterized the potent antiplasmodial activity of the aggregated protein dye YAT2150, whose presumed mode of action is the inhibition of protein aggregation in the malaria parasite. Using single-dose and ramping methods, assays were done to select Plasmodium falciparum parasit...

Full description

Saved in:
Bibliographic Details
Main Authors: Inés Bouzón-Arnáiz, Mukul Rawat, Rachael Coyle, Lionel Brice Feufack-Donfack, Malen Ea, Agnes Orban, Jean Popovici, Lucía Román-Álamo, Antonino Nicolò Fallica, Bárbara Domínguez-Asenjo, Javier Moreno, Elsa M. Arce, Ana Mallo-Abreu, Diego Muñoz-Torrero, Marcus C. S. Lee, Xavier Fernàndez-Busquets
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-025-85346-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585846681763840
author Inés Bouzón-Arnáiz
Mukul Rawat
Rachael Coyle
Lionel Brice Feufack-Donfack
Malen Ea
Agnes Orban
Jean Popovici
Lucía Román-Álamo
Antonino Nicolò Fallica
Bárbara Domínguez-Asenjo
Javier Moreno
Elsa M. Arce
Ana Mallo-Abreu
Diego Muñoz-Torrero
Marcus C. S. Lee
Xavier Fernàndez-Busquets
author_facet Inés Bouzón-Arnáiz
Mukul Rawat
Rachael Coyle
Lionel Brice Feufack-Donfack
Malen Ea
Agnes Orban
Jean Popovici
Lucía Román-Álamo
Antonino Nicolò Fallica
Bárbara Domínguez-Asenjo
Javier Moreno
Elsa M. Arce
Ana Mallo-Abreu
Diego Muñoz-Torrero
Marcus C. S. Lee
Xavier Fernàndez-Busquets
author_sort Inés Bouzón-Arnáiz
collection DOAJ
description Abstract We recently characterized the potent antiplasmodial activity of the aggregated protein dye YAT2150, whose presumed mode of action is the inhibition of protein aggregation in the malaria parasite. Using single-dose and ramping methods, assays were done to select Plasmodium falciparum parasites resistant to YAT2150 concentrations ranging from 3× to 0.25× the in vitro IC50 of the compound (in the two-digit nM range) and performed a cross-resistance assessment in P. falciparum lines harboring mutations that make them resistant to a variety of antimalarial drugs. Resistant parasites did not emerge in vitro after 60 days of incubation, which postulates YAT2150 as an ‘irresistible’ antimalarial. The lyophilized compound is stable for at least one year stored at 25 °C. Tests performed in clinical isolates indicated that YAT2150 had also strong activity against Plasmodium vivax (IC50 between 4 and 36 nM) and Leishmania infantum (1.27 and 1.11 µM), placing it as a unique compound with perspectives of becoming the first drug to be used against both malaria and leishmaniasis.
format Article
id doaj-art-67fa3dcf1419461c9e35fa5a64c6dffe
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-67fa3dcf1419461c9e35fa5a64c6dffe2025-01-26T12:27:03ZengNature PortfolioScientific Reports2045-23222025-01-0115111210.1038/s41598-025-85346-yYAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolatesInés Bouzón-Arnáiz0Mukul Rawat1Rachael Coyle2Lionel Brice Feufack-Donfack3Malen Ea4Agnes Orban5Jean Popovici6Lucía Román-Álamo7Antonino Nicolò Fallica8Bárbara Domínguez-Asenjo9Javier Moreno10Elsa M. Arce11Ana Mallo-Abreu12Diego Muñoz-Torrero13Marcus C. S. Lee14Xavier Fernàndez-Busquets15Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-University of Barcelona)Wellcome Sanger InstituteWellcome Sanger InstituteMalaria Research Unit, Institut Pasteur du CambodgeMalaria Research Unit, Institut Pasteur du CambodgeMalaria Research Unit, Institut Pasteur du CambodgeMalaria Research Unit, Institut Pasteur du CambodgeBarcelona Institute for Global Health (ISGlobal, Hospital Clínic-University of Barcelona)Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-University of Barcelona)WHO Collaborating Centre for Leishmaniasis, National Centre for Microbiology Instituto de Salud Carlos IIIWHO Collaborating Centre for Leishmaniasis, National Centre for Microbiology Instituto de Salud Carlos IIILaboratory of Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, University of BarcelonaLaboratory of Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, University of BarcelonaLaboratory of Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, University of BarcelonaWellcome Sanger InstituteBarcelona Institute for Global Health (ISGlobal, Hospital Clínic-University of Barcelona)Abstract We recently characterized the potent antiplasmodial activity of the aggregated protein dye YAT2150, whose presumed mode of action is the inhibition of protein aggregation in the malaria parasite. Using single-dose and ramping methods, assays were done to select Plasmodium falciparum parasites resistant to YAT2150 concentrations ranging from 3× to 0.25× the in vitro IC50 of the compound (in the two-digit nM range) and performed a cross-resistance assessment in P. falciparum lines harboring mutations that make them resistant to a variety of antimalarial drugs. Resistant parasites did not emerge in vitro after 60 days of incubation, which postulates YAT2150 as an ‘irresistible’ antimalarial. The lyophilized compound is stable for at least one year stored at 25 °C. Tests performed in clinical isolates indicated that YAT2150 had also strong activity against Plasmodium vivax (IC50 between 4 and 36 nM) and Leishmania infantum (1.27 and 1.11 µM), placing it as a unique compound with perspectives of becoming the first drug to be used against both malaria and leishmaniasis.https://doi.org/10.1038/s41598-025-85346-y
spellingShingle Inés Bouzón-Arnáiz
Mukul Rawat
Rachael Coyle
Lionel Brice Feufack-Donfack
Malen Ea
Agnes Orban
Jean Popovici
Lucía Román-Álamo
Antonino Nicolò Fallica
Bárbara Domínguez-Asenjo
Javier Moreno
Elsa M. Arce
Ana Mallo-Abreu
Diego Muñoz-Torrero
Marcus C. S. Lee
Xavier Fernàndez-Busquets
YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates
Scientific Reports
title YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates
title_full YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates
title_fullStr YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates
title_full_unstemmed YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates
title_short YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates
title_sort yat2150 is irresistible in plasmodium falciparum and active against plasmodium vivax and leishmania clinical isolates
url https://doi.org/10.1038/s41598-025-85346-y
work_keys_str_mv AT inesbouzonarnaiz yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT mukulrawat yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT rachaelcoyle yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT lionelbricefeufackdonfack yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT malenea yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT agnesorban yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT jeanpopovici yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT luciaromanalamo yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT antoninonicolofallica yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT barbaradominguezasenjo yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT javiermoreno yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT elsamarce yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT anamalloabreu yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT diegomunoztorrero yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT marcuscslee yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates
AT xavierfernandezbusquets yat2150isirresistibleinplasmodiumfalciparumandactiveagainstplasmodiumvivaxandleishmaniaclinicalisolates